Futura Medical plc
FAMDF
$0.01
-$0.01-29.41%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -3.46% | 92.73% | 361.85% | 376.66% | 405.02% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -3.46% | 92.73% | 361.85% | 376.66% | 405.02% |
| Cost of Revenue | 6.25% | 76.98% | 228.61% | 236.20% | 249.66% |
| Gross Profit | -8.09% | 101.24% | 461.33% | 487.44% | 540.74% |
| SG&A Expenses | 23.53% | 13.30% | 4.55% | 44.28% | 117.81% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.22% | 20.48% | 29.22% | 46.60% | 71.41% |
| Operating Income | -56.07% | 54.61% | 118.23% | 77.40% | 26.66% |
| Income Before Tax | -59.68% | 54.60% | 119.11% | 78.59% | 28.75% |
| Income Tax Expenses | 110.55% | 105.35% | 100.15% | 74.14% | 61.99% |
| Earnings from Continuing Operations | -74.01% | 51.16% | 120.21% | 79.06% | 23.09% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -74.01% | 51.16% | 120.21% | 79.06% | 23.09% |
| EBIT | -56.07% | 54.61% | 118.23% | 77.40% | 26.66% |
| EBITDA | -57.72% | 55.84% | 120.40% | 79.03% | 27.90% |
| EPS Basic | -73.08% | 51.63% | 119.78% | 79.42% | 26.07% |
| Normalized Basic EPS | -56.07% | 55.86% | 118.68% | 78.70% | 30.97% |
| EPS Diluted | -71.52% | 50.93% | 118.68% | 78.60% | 25.12% |
| Normalized Diluted EPS | -56.07% | 55.86% | 118.68% | 78.70% | 30.97% |
| Average Basic Shares Outstanding | 0.70% | 1.56% | 2.44% | 3.44% | 4.46% |
| Average Diluted Shares Outstanding | -1.68% | 1.77% | 5.38% | 6.29% | 7.22% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |